Menu
GWAS Study

A combined analysis of genome-wide association studies in breast cancer.

Li J, Humphreys K, Heikkinen T et al.

20872241 PubMed ID
GWAS Study Type
23390 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LJ
Li J
HK
Humphreys K
HT
Heikkinen T
AK
Aittomäki K
BC
Blomqvist C
PP
Pharoah PD
DA
Dunning AM
AS
Ahmed S
HM
Hooning MJ
MJ
Martens JW
VD
van den Ouweland AM
AL
Alfredsson L
PA
Palotie A
PL
Peltonen-Palotie L
IA
Irwanto A
LH
Low HQ
TG
Teoh GH
TA
Thalamuthu A
ED
Easton DF
NH
Nevanlinna H
LJ
Liu J
CK
Czene K
HP
Hall P
Chapter II

Abstract

Summary of the research findings

In an attempt to identify common disease susceptibility alleles for breast cancer, we performed a combined analysis of three genome-wide association studies (GWAS), involving 2,702 women of European ancestry with invasive breast cancer and 5,726 controls. Tests for association were performed for 285,984 SNPs. Evidence for association with SNPs in genes in specific pathways was assessed using a permutation-based approach. We confirmed associations with loci reported by previous GWAS on 1p11.2, 2q35, 3p, 5p12, 8q24, 10q23.13, 14q24.1 and 16q. Six SNPs with the strongest signals of association with breast cancer, and which have not been reported previously, were typed in two further studies; however, none of the associations could be confirmed. Suggestive evidence for an excess of associations was found for genes involved in the regulation of actin cytoskeleton, glycan degradation, alpha-linolenic acid metabolism, circadian rhythm, hematopoietic cell lineage and drug metabolism. Androgen and oestrogen metabolism, a pathway previously found to be associated with the development of postmenopausal breast cancer, was marginally significant (P = 0.051 [unadjusted]). These results suggest that further analysis of SNPs in these pathways may identify associations that would be difficult to detect through agnostic single SNP analyses. More effort focused in these aspects of oncology can potentially open up promising avenues for the understanding of breast cancer and its prevention.

2,702 European ancestry female cases, 5,726 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

23390
Total Participants
GWAS
Study Type
Yes
Replicated
Up to 7,386 cases, 7,576 controls
Replication Participants
European
Ancestry
Finland, Sweden
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.